Updated data from two series in a cancer mortality study for a total of 412
Japanese Thorotrast patients were combined. The rate ratio for all deaths
of Thorotrast patients, compared to controls, started to increase after a l
atent period of 20 years after injection of Thorotrast. Rate ratios for liv
er cancer, liver cirrhosis, leukemia and lung cancer were 35.9, 6.9, 12.5 a
nd 2.0 times higher, respectively, than those for controls. (C) 1999 by Rad
iation Research Society.